ArticleJournal of inflammation research2026
ANCA-Associated Vasculitis with Predominant Peripheral and Central Nervous System Involvement: A Case Report.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: ANCA-associated vasculitis (AAV) is an immune-mediated multi-system disease. It can present with neurological involvement as its predominant manifestation. We report a case of AAV with predominant peripheral and central nervous system involvement. Case Presentation: A 62-year-old male presented with fever and asymmetric weakness and pain in the lower limbs. Electrophysiological studies revealed asymmetric axonal damage in both lower limbs. During hospitalization, he developed acute bulbar palsy. Brain MRI confirmed bilateral basal ganglia infarction. Ancillary tests indicated involvement of the lungs, kidneys, and hematological systems, along with positive MPO-ANCA (p-ANCA), confirming the diagnosis of AAV. His symptoms gradually improved following treatment with glucocorticoids and immunosuppressants. At the 6-month follow-up, his symptoms were largely resolved. Conclusion: The presence of asymmetric axonal neuropathy or atypical non-atherosclerotic cerebral infarction, particularly when accompanied by multisystem involvement, should raise suspicion for AAV. Early diagnosis and prompt treatment significantly improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.